Search results
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And...
Benzinga via Yahoo Finance· 3 hours agoThe terms of the agreement include: A co-exclusive license to co-commercialize Novavax’s current...
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 3 hours ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
Biotech Rockets 125% On Sanofi Covid Vaccine Agreement
Investor's Business Daily· 2 hours agoNovavax will receive as much as $1.2 billion as part of a Covid vaccine licensing deal with Sanofi.
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 3 hours agoNovavax announced a $1.2 billion licensing partnership with French pharmaceutical company Sanofi on...
France’s Sanofi in COVID-19 vaccine deal with Novavax
WSAU Wausau· 11 hours agoPARIS (Reuters) - Sanofi on Friday announced it has reached a licensing agreement with Novavax to...
Novavax shares skyrocket after billion-dollar licensing deal with Sanofi By Proactive Investors
Investing.com· 56 minutes agoThe deal encompasses the commercialization of a combined COVID-19 and flu shot, marking a pivotal...
Novavax, Sanofi Ink Deal to Commercialize COVID-19 Vaccine to Jointly Produce Combination Shots -...
EconoTimes· 8 hours agoNovavax, Inc., a biotechnology company headquartered in Gaithersburg, Maryland, revealed on Friday,...
Novavax Stock Doubles on $1.2B Sanofi Deal for COVID-19, Flu Vaccines
Investopedia· 10 hours agoNovavax (NVAX) shares more than doubled in intraday trading Friday after announcing a $1.2 billion...
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize ...
Benzinga· 11 hours agoSanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel ...
Novavax Stock Surges 140% on $1.4 Billion Deal With Sanofi
Barrons.com· 3 hours agoNovavax the pharmaceutical company that last year warned that falling sales of its Covid-19 vaccine...